CHIMERIX
CMRX Insider Trades:
all
Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
10b5-1
Director
10% Owner
Mcap/AUM
2025-04-21
2025-04-21
LASPALUTO MICHELLE
CHIEF FINANCIAL OFFICER
D - Sale to Issuer
Employee Stock Option (Right to Buy)
-834K
14
$463.17M
2025-04-21
2025-04-21
MIDDLETON FRED
D - Sale to Issuer
Employee Stock Option (Right to Buy)
-324K
8
$463.17M
2025-04-21
2025-04-21
RIGA THOMAS
COO and CCO
D - Sale to Issuer
Employee Stock Option (Right to Buy)
-1.13M
2
$463.17M
2025-04-21
2025-04-21
JAKEMAN DAVID
VP OF FINANCE AND ACCOUNTING
D - Sale to Issuer
Common Stock
-156K
$9.00
-1.41M
1
$463.17M
2025-04-21
2025-04-21
SHERMAN MICHAEL
Chief Executive Officer
D - Sale to Issuer
Employee Stock Option (Right to Buy)
-3.97M
6
$463.17M
2025-04-21
2025-04-21
SHERMAN MICHAEL
Chief Executive Officer
D - Sale to Issuer
Common Stock
-423K
$9.00
-3.81M
3
$463.17M
2025-04-21
2025-04-21
VAKIENER VICTORIA
D - Sale to Issuer
Employee Stock Option (Right to Buy)
-265K
5
$463.17M
2025-04-21
2025-04-21
ALRUTZ MICHAEL ALBERT
SVP AND GENERAL COUNSEL
D - Sale to Issuer
Employee Stock Option (Right to Buy)
-1.59M
11
$463.17M
2025-04-21
2025-04-21
ALRUTZ MICHAEL ALBERT
SVP AND GENERAL COUNSEL
D - Sale to Issuer
Common Stock
-217K
$9.00
-1.95M
1
$463.17M
2025-04-21
2025-04-21
ANDRIOLE MICHAEL
PRESIDENT AND CEO
D - Sale to Issuer
Employee Stock Option (Right to Buy)
-2.94M
8
$463.17M
2025-04-21
2025-04-21
ANDRIOLE MICHAEL
PRESIDENT AND CEO
D - Sale to Issuer
Common Stock
-631K
$9.00
-5.68M
1
$463.17M
2025-04-21
2025-04-21
DECKER LISA LYNN
D - Sale to Issuer
Employee Stock Option (Right to Buy)
-160K
2
$463.17M
2025-04-21
2025-04-21
DEMSKI MARTHA
D - Sale to Issuer
Employee Stock Option (Right to Buy)
-321K
10
$463.17M
2025-04-21
2025-04-21
JAKEMAN DAVID
VP OF FINANCE AND ACCOUNTING
D - Sale to Issuer
Employee Stock Option (Right to Buy)
-312K
15
$463.17M
2025-04-21
2025-04-21
ALRUTZ MICHAEL ALBERT
SVP AND GENERAL COUNSEL
D - Sale to Issuer
Employee Stock Option (Right to Buy)
-1.59M
11
$463.17M
2025-04-21
2025-04-21
ALRUTZ MICHAEL ALBERT
SVP AND GENERAL COUNSEL
D - Sale to Issuer
Common Stock
-217K
$9.00
-1.95M
1
$463.17M
2025-04-21
2025-04-21
ANDRIOLE MICHAEL
PRESIDENT AND CEO
D - Sale to Issuer
Employee Stock Option (Right to Buy)
-2.94M
8
$463.17M
2025-04-21
2025-04-21
ANDRIOLE MICHAEL
PRESIDENT AND CEO
D - Sale to Issuer
Common Stock
-631K
$9.00
-5.68M
1
$463.17M
2025-04-21
2025-04-21
DECKER LISA LYNN
D - Sale to Issuer
Employee Stock Option (Right to Buy)
-160K
2
$463.17M
2025-04-21
2025-04-21
DEMSKI MARTHA
D - Sale to Issuer
Employee Stock Option (Right to Buy)
-321K
10
$463.17M
2025-04-21
2025-04-21
JAKEMAN DAVID
VP OF FINANCE AND ACCOUNTING
D - Sale to Issuer
Common Stock
-156K
$9.00
-1.41M
1
$463.17M
2025-04-21
2025-04-21
KOZIN MARC
D - Sale to Issuer
Employee Stock Option (Right to Buy)
-160K
2
$463.17M
2025-04-21
2025-04-21
LASPALUTO MICHELLE
CHIEF FINANCIAL OFFICER
D - Sale to Issuer
Common Stock
-182K
$9.00
-1.63M
1
$463.17M
2025-04-21
2025-04-21
MELEMED ALLEN
CHIEF MEDICAL OFFICER
D - Sale to Issuer
Employee Stock Option (Right to Buy)
-1.43M
6
$463.17M
2025-04-21
2025-04-21
MELEMED ALLEN
CHIEF MEDICAL OFFICER
D - Sale to Issuer
Common Stock
-174K
$9.00
-1.56M
1
$463.17M
2025-04-21
2025-04-21
MEYER ROBERT
D - Sale to Issuer
Employee Stock Option (Right to Buy)
-324K
8
$463.17M
2025-04-21
2025-04-21
MULTANI PRATIK
D - Sale to Issuer
Employee Stock Option (Right to Buy)
-300K
6
$463.17M
2025-04-21
2025-04-21
RIGA THOMAS
COO and CCO
D - Sale to Issuer
Common Stock
-60,828
$9.00
-547K
1
$463.17M
2025-04-21
2025-04-21
SHERMAN MICHAEL
Chief Executive Officer
D - Sale to Issuer
Employee Stock Option (Right to Buy)
-3.97M
6
$463.17M
2025-04-21
2025-04-21
SHERMAN MICHAEL
Chief Executive Officer
D - Sale to Issuer
Common Stock
-423K
$9.00
-3.81M
3
$463.17M
2025-04-21
2025-04-21
VAKIENER VICTORIA
D - Sale to Issuer
Employee Stock Option (Right to Buy)
-265K
5
$463.17M
2025-04-21
2025-04-21
JAKEMAN DAVID
VP OF FINANCE AND ACCOUNTING
D - Sale to Issuer
Employee Stock Option (Right to Buy)
-312K
15
$463.17M
2025-04-21
2025-04-21
KOZIN MARC
D - Sale to Issuer
Employee Stock Option (Right to Buy)
-160K
2
$463.17M
2025-04-21
2025-04-21
LASPALUTO MICHELLE
CHIEF FINANCIAL OFFICER
D - Sale to Issuer
Employee Stock Option (Right to Buy)
-834K
14
$463.17M
2025-04-21
2025-04-21
LASPALUTO MICHELLE
CHIEF FINANCIAL OFFICER
D - Sale to Issuer
Common Stock
-182K
$9.00
-1.63M
1
$463.17M
2025-04-21
2025-04-21
MELEMED ALLEN
CHIEF MEDICAL OFFICER
D - Sale to Issuer
Employee Stock Option (Right to Buy)
-1.43M
6
$463.17M
2025-04-21
2025-04-21
MELEMED ALLEN
CHIEF MEDICAL OFFICER
D - Sale to Issuer
Common Stock
-174K
$9.00
-1.56M
1
$463.17M
2025-04-21
2025-04-21
MEYER ROBERT
D - Sale to Issuer
Employee Stock Option (Right to Buy)
-324K
8
$463.17M
2025-04-21
2025-04-21
MIDDLETON FRED
D - Sale to Issuer
Employee Stock Option (Right to Buy)
-324K
8
$463.17M
2025-04-21
2025-04-21
MULTANI PRATIK
D - Sale to Issuer
Employee Stock Option (Right to Buy)
-300K
6
$463.17M
2025-04-21
2025-04-21
RIGA THOMAS
COO and CCO
D - Sale to Issuer
Employee Stock Option (Right to Buy)
-1.13M
2
$463.17M
2025-04-21
2025-04-21
RIGA THOMAS
COO and CCO
D - Sale to Issuer
Common Stock
-60,828
$9.00
-547K
1
$463.17M
2025-02-13
2025-02-14
ALRUTZ MICHAEL ALBERT
SVP AND GENERAL COUNSEL
S - Sale
Common Stock
-1,600
$5.00
-8,000
1
$463.17M
2025-02-13
2025-02-14
ANDRIOLE MICHAEL
PRESIDENT AND CEO
S - Sale
Common Stock
-7,370
$5.00
-36,850
1
$463.17M
2025-02-13
2025-02-14
JAKEMAN DAVID
VP OF FINANCE AND ACCOUNTING
S - Sale
Common Stock
-300
$5.00
-1,500
1
$463.17M
2025-02-13
2025-02-14
LASPALUTO MICHELLE
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-2,260
$5.00
-11,300
1
$463.17M
2025-02-13
2025-02-14
MELEMED ALLEN
CHIEF MEDICAL OFFICER
S - Sale
Common Stock
-3,065
$5.00
-15,325
1
$463.17M
2025-02-13
2025-02-13
LASPALUTO MICHELLE
CHIEF FINANCIAL OFFICER
S - Sale
-2,500
$4.00
-10,000
1
$463.17M
2025-01-30
2025-01-31
ANDRIOLE MICHAEL
PRESIDENT AND CEO
S - Sale
Common Stock
-2,350
$4.00
-9,400
1
$463.17M
2025-01-30
2025-01-31
JAKEMAN DAVID
VP OF FINANCE AND ACCOUNTING
S - Sale
Common Stock
-2,800
$4.00
-11,200
1
$463.17M
2025-01-30
2025-01-31
LASPALUTO MICHELLE
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-1,015
$4.00
-4,060
1
$463.17M
2025-01-30
2025-01-30
JAKEMAN DAVID
VP OF FINANCE AND ACCOUNTING
S - Sale
-3,000
$4.00
-12,000
1
$463.17M
2025-01-30
2025-01-30
JAKEMAN DAVID
VP OF FINANCE AND ACCOUNTING
S - Sale
-3,000
$4.00
-12,000
1
$463.17M
2025-01-30
2025-01-30
JAKEMAN DAVID
VP OF FINANCE AND ACCOUNTING
S - Sale
-3,000
$4.00
-12,000
1
$463.17M
2025-01-07
2025-01-10
ALRUTZ MICHAEL ALBERT
SVP AND GENERAL COUNSEL
A - Grant
Stock Option (Right to Buy)
250K
$0.00
1
$463.17M
2025-01-07
2025-01-10
ALRUTZ MICHAEL ALBERT
SVP AND GENERAL COUNSEL
A - Grant
Common Stock
41,667
$0.00
1
$463.17M
2025-01-07
2025-01-10
ANDRIOLE MICHAEL
PRESIDENT AND CEO
A - Grant
Stock Option (Right to Buy)
900K
$0.00
1
$463.17M
2025-01-07
2025-01-10
JAKEMAN DAVID
VP OF FINANCE AND ACCOUNTING
A - Grant
Stock Option (Right to Buy)
65,000
$0.00
1
$463.17M
2025-01-07
2025-01-10
JAKEMAN DAVID
VP OF FINANCE AND ACCOUNTING
A - Grant
Common Stock
10,855
$0.00
1
$463.17M
2025-01-07
2025-01-10
LASPALUTO MICHELLE
CHIEF FINANCIAL OFFICER
A - Grant
Stock Option (Right to Buy)
250K
$0.00
1
$463.17M
2025-01-07
2025-01-10
LASPALUTO MICHELLE
CHIEF FINANCIAL OFFICER
A - Grant
Common Stock
41,667
$0.00
1
$463.17M
2025-01-07
2025-01-10
MELEMED ALLEN
CHIEF MEDICAL OFFICER
A - Grant
Stock Option (Right to Buy)
275K
$0.00
1
$463.17M
2025-01-07
2025-01-10
RIGA THOMAS
COO and CCO
A - Grant
Stock Option (Right to Buy)
325K
$0.00
1
$463.17M
2024-08-08
2024-08-09
ANDRIOLE MICHAEL
PRESIDENT AND CEO
S - Sale
Common Stock
-1,285
$1.00
-1,285
1
$463.17M
2024-06-20
2024-06-21
SHERMAN MICHAEL
Chief Executive Officer
A - Grant
Stock Option (Right to Buy)
60,000
$0.00
1
$463.17M
2024-02-14
2024-02-16
ANDRIOLE MICHAEL
PRESIDENT AND CEO
S - Sale
Common Stock
-1,744
$1.00
-1,744
1
$463.17M
2024-02-14
2024-02-16
JAKEMAN DAVID
VP OF FINANCE AND ACCOUNTING
S - Sale
Common Stock
-2,660
$1.00
-2,660
1
$463.17M
2024-02-14
2024-02-16
LASPALUTO MICHELLE
CHIEF FINANCIAL OFFICER
S - Sale
Common Stock
-1,940
$1.00
-1,940
1
$463.17M
2024-02-01
2024-02-02
LASPALUTO MICHELLE
CHIEF FINANCIAL OFFICER
A - Grant
Stock Option (Right to Buy)
150K
$0.00
1
$463.17M
2024-02-01
2024-02-02
LASPALUTO MICHELLE
CHIEF FINANCIAL OFFICER
A - Grant
Common Stock
25,000
$0.00
1
$463.17M
2024-02-01
2024-02-02
MELEMED ALLEN
CHIEF MEDICAL OFFICER
A - Grant
Stock Option (Right to Buy)
169K
$0.00
1
$463.17M
2024-02-01
2024-02-02
ALRUTZ MICHAEL ALBERT
SVP AND GENERAL COUNSEL
A - Grant
Stock Option (Right to Buy)
131K
$0.00
1
$463.17M
2024-02-01
2024-02-02
ALRUTZ MICHAEL ALBERT
SVP AND GENERAL COUNSEL
A - Grant
Common Stock
21,875
$0.00
1
$463.17M
2024-02-01
2024-02-02
ANDRIOLE MICHAEL
PRESIDENT AND CEO
A - Grant
Stock Option (Right to Buy)
503K
$0.00
1
$463.17M
2024-02-01
2024-02-02
JAKEMAN DAVID
VP OF FINANCE AND ACCOUNTING
A - Grant
Stock Option (Right to Buy)
64,500
$0.00
1
$463.17M
2024-02-01
2024-02-02
JAKEMAN DAVID
VP OF FINANCE AND ACCOUNTING
A - Grant
Common Stock
10,750
$0.00
1
$463.17M
2023-12-01
2023-12-04
LASPALUTO MICHELLE
Chief Financial Officer
A - Grant
Employee Stock Option (Right to Buy)
17,000
$0.00
1
$463.17M
2023-11-16
2023-11-16
RIGA THOMAS
COO and CCO
A - Grant
Employee Stock Option (Right to Buy)
800K
$0.00
1
$463.17M
2023-09-28
2023-09-28
JAKEMAN DAVID
VP of Finance and Accounting
S - Sale
Common Stock
-3,610
$1.00
-3,610
1
$463.17M
2023-09-20
2023-09-20
JAKEMAN DAVID
VP of Finance and Accounting
A - Grant
Stock Option (Right to Buy)
18,000
$0.00
1
$463.17M
2023-08-01
2023-08-01
ANDRIOLE MICHAEL
President and CEO
A - Grant
Stock Option (Right to Buy)
150K
$0.00
1
$463.17M
2023-08-01
2023-08-01
ANDRIOLE MICHAEL
President and CEO
A - Grant
Common Stock
25,000
$1.00
25,000
1
$463.17M
2023-05-18
2023-05-19
ANDRIOLE MICHAEL
Chief Business Officer and CFO
P - Purchase
Common Stock
51,700
$1.00
51,700
1
$463.17M
2023-05-12
2023-05-16
SHERMAN MICHAEL
Chief Executive Officer
P - Purchase
Common Stock
87,000
$1.00
87,000
2
$463.17M
2023-01-26
2023-01-26
JAKEMAN DAVID
Principal Accounting Officer
S - Sale
Common Stock
-3,230
$2.00
-6,460
1
$463.17M
2023-01-17
2023-01-19
ALRUTZ MICHAEL ALBERT
Principal Executive Officer
A - Grant
Stock Option (Right to Buy)
129K
$0.00
1
$463.17M
2023-01-17
2023-01-19
ALRUTZ MICHAEL ALBERT
Principal Executive Officer
A - Grant
Common Stock
21,450
$0.00
1
$463.17M
2023-01-17
2023-01-19
ANDRIOLE MICHAEL
Chief Business Officer and CFO
A - Grant
Stock Option (Right to Buy)
193K
$0.00
1
$463.17M
2023-01-17
2023-01-19
ANDRIOLE MICHAEL
Chief Business Officer and CFO
A - Grant
Common Stock
32,175
$0.00
1
$463.17M
2023-01-17
2023-01-19
JAKEMAN DAVID
Principal Accounting Officer
A - Grant
Stock Option (Right to Buy)
24,950
$0.00
1
$463.17M
2023-01-17
2023-01-19
JAKEMAN DAVID
Principal Accounting Officer
A - Grant
Common Stock
12,450
$0.00
1
$463.17M
2023-01-17
2023-01-19
MELEMED ALLEN
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
154K
$0.00
1
$463.17M
2023-01-17
2023-01-19
SHERMAN MICHAEL
Chief Executive Officer
A - Grant
Stock Option (Right to Buy)
557K
$0.00
1
$463.17M
2023-01-17
2023-01-19
SHERMAN MICHAEL
Chief Executive Officer
A - Grant
Common Stock
92,950
$0.00
1
$463.17M
2022-09-29
2022-09-30
JAKEMAN DAVID
Principal Accounting Officer
S - Sale
Common Stock
-4,400
$2.00
-8,800
1
$463.17M
2022-08-25
2022-08-29
ANDRIOLE MICHAEL
Chief Business Officer and CFO
M - Exercise
Employee Stock Option (Right to Buy)
-50,000
$0.00
1
$463.17M
2022-08-25
2022-08-29
ANDRIOLE MICHAEL
Chief Business Officer and CFO
M - Exercise
Common Stock
50,000
$2.00
100K
1
$463.17M
2022-07-25
2022-07-27
SHERMAN MICHAEL
Chief Executive Officer
M - Exercise
Employee Stock Option (Right to Buy)
-100K
$0.00
1
$463.17M
2022-07-25
2022-07-27
SHERMAN MICHAEL
Chief Executive Officer
M - Exercise
Common Stock
100K
$2.00
200K
1
$463.17M
2022-07-25
2022-07-26
SHERMAN MICHAEL
Chief Executive Officer
M - Exercise
Employee Stock Option (Right to Buy)
-100K
$0.00
1
$463.17M
2022-07-25
2022-07-26
SHERMAN MICHAEL
Chief Executive Officer
M - Exercise
Common Stock
100K
$2.00
200K
1
$463.17M
2022-05-17
2022-05-18
ANDRIOLE MICHAEL
Chief Business Officer and CFO
P - Purchase
Common Stock
15,000
$2.00
30,000
1
$463.17M
2022-02-04
2022-02-04
JAKEMAN DAVID
Principal Accounting Officer
S - Sale
Common Stock
-3,300
$6.00
-19,800
1
$463.17M
2022-01-18
2022-01-20
JAKEMAN DAVID
Principal Accounting Officer
A - Grant
Common Stock
14,900
$0.00
1
$463.17M
2022-01-18
2022-01-20
SHERMAN MICHAEL
Chief Executive Officer
A - Grant
Stock Option (Right to Buy)
875K
$0.00
1
$463.17M
2022-01-18
2022-01-20
MELEMED ALLEN
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
240K
$0.00
1
$463.17M
2022-01-18
2022-01-20
ANDRIOLE MICHAEL
Chief Business Officer and CFO
A - Grant
Stock Option (Right to Buy)
300K
$0.00
1
$463.17M
2022-01-18
2022-01-20
JAKEMAN DAVID
Principal Accounting Officer
A - Grant
Stock Option (Right to Buy)
29,900
$0.00
1
$463.17M
2021-09-30
2021-09-30
JAKEMAN DAVID
Principal Accounting Officer
S - Sale
Common Stock
-4,590
$6.00
-27,540
1
$463.17M
2021-09-14
2021-09-16
CANTEX PHARMACEUTICALS, INC.
S - Sale
Common Stock, par value $0.001
-6.50M
$6.00
-39M
1
$463.17M
2021-04-05
2021-04-07
JAKEMAN DAVID
Principal Accounting Officer
M - Exercise
Stock Option (Right to Buy)
-5,250
$0.00
1
$463.17M
2021-04-05
2021-04-07
JAKEMAN DAVID
Principal Accounting Officer
M - Exercise
Common Stock
5,250
$2.00
10,500
1
$463.17M
2021-04-05
2021-04-07
JAKEMAN DAVID
Principal Accounting Officer
S - Sale
Common Stock
-1,284
$10.00
-12,840
1
$463.17M
2021-01-28
2021-01-29
JAKEMAN DAVID
Principal Accounting Officer
S - Sale
Common Stock
-3,211
$9.00
-28,899
1
$463.17M
2021-01-22
2021-01-26
JAKEMAN DAVID
Principal Accounting Officer
A - Grant
Stock Option (Right to Buy)
30,000
$0.00
1
$463.17M
2021-01-22
2021-01-26
JAKEMAN DAVID
Principal Accounting Officer
A - Grant
Common Stock
15,000
$0.00
1
$463.17M
2021-01-22
2021-01-26
MELEMED ALLEN
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
190K
$0.00
1
$463.17M
2021-01-22
2021-01-26
SHERMAN MICHAEL
Chief Executive Officer
A - Grant
Stock Option (Right to Buy)
700K
$0.00
1
$463.17M
2021-01-22
2021-01-26
ANDRIOLE MICHAEL
Chief Business Officer and CFO
A - Grant
Stock Option (Right to Buy)
250K
$0.00
1
$463.17M
2020-12-21
2020-12-23
JAKEMAN DAVID
Principal Accounting Officer
A - Grant
Stock Option (Right to Buy)
1,500
$0.00
1
$463.17M
2020-10-02
2020-10-02
JAKEMAN DAVID
Principal Accounting Officer
S - Sale
Common Stock
-4,270
$2.00
-8,540
1
$463.17M
2020-06-19
2020-06-23
MELEMED ALLEN
Chief Medical Officer
A - Grant
Employee Stock Option (Right to Buy)
400K
$0.00
1
$463.17M
2020-03-16
2020-03-17
ANDRIOLE MICHAEL
Chief Business Officer
P - Purchase
Common Stock
33,300
$1.00
33,300
1
$463.17M
2020-03-12
2020-03-16
SHERMAN MICHAEL
Chief Executive Officer
P - Purchase
Common Stock
72,995
$1.00
72,995
1
$463.17M
2020-02-10
2020-02-11
NICHOLS GARRETT
Chief Medical Officer
S - Sale
Common Stock
-8,805
$2.00
-17,610
1
$463.17M
2020-02-07
2020-02-11
NICHOLS GARRETT
Chief Medical Officer
S - Sale
Common Stock
-2,550
$2.00
-5,100
1
$463.17M
2020-02-07
2020-02-11
JAKEMAN DAVID
Principal Accounting Officer
S - Sale
Common Stock
-2,290
$2.00
-4,580
1
$463.17M
2020-01-21
2020-01-23
SHERMAN MICHAEL
Chief Executive Officer
A - Grant
Stock Option (Right to Buy)
633K
$0.00
1
$463.17M
2020-01-21
2020-01-23
JAKEMAN DAVID
Principal Accounting Officer
A - Grant
Stock Option (Right to Buy)
28,320
$0.00
1
$463.17M
2020-01-21
2020-01-23
ANDRIOLE MICHAEL
Chief Business Officer
A - Grant
Stock Option (Right to Buy)
193K
$0.00
1
$463.17M
2020-01-21
2020-01-23
JAKEMAN DAVID
Principal Accounting Officer
A - Grant
Common Stock
14,160
$0.00
1
$463.17M
2020-01-21
2020-01-23
NICHOLS GARRETT
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
193K
$0.00
1
$463.17M
2020-01-07
2020-01-08
NICHOLS GARRETT
Chief Medical Officer
S - Sale
Common Stock
-30,680
$2.00
-61,360
1
$463.17M